Read articles from Global

January 27, 2025 by regulatorwatch.com

Seeds of public health’s war on vaping were planted decades ago during the fight against secondhand smoke. What began as a strategy to combat smoking has evolved into a campaign of deception—one that distorts science, spreads misinformation, and undermines harm reduction. Joining us again for Part 2 of our special series is Dr. Michael Siegel, a professor of public health at Tufts University and long-time advocate for tobacco harm reduction.

January 27, 2025 by gfn.tv

Public health’s war on vaping didn’t start with vaping—it began decades ago with secondhand smoke. The same deceptive tactics now target tobacco harm reduction. How did it begin, and where does it lead? Don’t miss this special two-part episode featuring renowned tobacco control expert Dr. Michael Siegel.

January 27, 2025 by gfn.tv

Public health’s war on vaping didn’t start with vaping—it began decades ago with secondhand smoke. The same deceptive tactics now target tobacco harm reduction. How did it begin, and where does it lead? Don’t miss this special two-part episode featuring renowned tobacco control expert Dr. Michael Siegel.

January 24, 2025 by planetofthevapes.co.uk

CAPHRA is urging Asia Pacific Health Ministries to include consumer perspectives in tobacco policies for the upcoming FCTC COP11 in November 2025. The organization emphasizes stakeholder participation for consumer voices, highlighting the importance of their insights in decision-making. CAPHRA clarifies its independent status and grassroots advocacy for harm reduction in the region, emphasizing evidence-based policies. They aim to represent adult consumers' rights to safer nicotine products and challenge exclusion based on FCTC Article 5.3. CAPHRA advocates for inclusive processes that benefit all citizens.

January 24, 2025 by independent.co.uk

A study by University College London reveals the increase in "dual use" of smoking and vaping among adults in England, particularly in young adults. Researchers noted a rise from 3.5% in 2016 to 5.2% in 2024, with 34% of smokers now also vaping. The proportion of smokers who vape daily and smoke less has increased, possibly indicating a shift towards harm reduction. Concerns were raised about misconceptions on vaping harms hindering smoking cessation efforts. Accurate messaging on smoking and vaping risks is crucial for informed decision-making. Initiatives like the swap-to-stop scheme aim to support full switching from smoking to vaping for improved public health.

January 23, 2025 by dentistry.co.uk

A University College London (UCL) study funded by Cancer Research UK analyzed survey data from 2016 to 2024, revealing a sharp rise in dual use of cigarettes and vapes. The percentage of people engaging in both behaviors increased from 3.5% to 5.2%, equivalent to a shift from 1 in 30 people to 1 in 20. The most significant surge occurred in 2021, coinciding with the growing popularity of e-cigarettes. The increase was especially pronounced among young adults, with two-thirds of 18- to 24-year-olds now smoking and vaping, compared to just one in five in 2016. The study also highlighted changes in dual-use habits: daily smokers who don’t vape daily dropped from 32% to 15%, while daily vapers who don’t smoke daily rose from 8% to 22%. Researchers attribute these changes to the growing number of frequent vapers among young adult dual users.

January 23, 2025 by nature.com

A cross-sectional study of 107,249 American adults found no independent link between e-cigarette use and PCS after COVID-19 infection. Factors associated with PCS included female gender, cigarette smoking, and other health conditions. Sensitivity analyses supported the study's conclusions. Previous research on e-cigarettes and PCS showed mixed results, with some suggesting potential harm. The lack of mediation by COPD contradicts previous findings. Mechanisms linking e-cigarettes to health issues were explored. The study had strengths in representation and analytical methods but acknowledged limitations in missing data and self-reporting bias.

January 23, 2025 by baohaiduong.vn

The Ministry of Health is increasing inspections and penalties for electronic cigarette offenses. Offenders face fines of 1 to 2 million VND and repeat violations will result in double fines. Authorities confiscated e-cigarette products from businesses and are enforcing Resolution No. 173/2024/QH15 to ban production and use of these products by 2025. The Ministry is amending Decree No. 117/2020/ND-CP to propose fines and confiscation of e-cigarettes for violators. Measures include destruction of products and notifying violators' workplaces or schools for appropriate action. The Ministry emphasizes the prohibition of e-cigarettes and tobacco products, urging strict enforcement and public awareness efforts.

January 23, 2025 by baohaiduong.vn

The Ministry of Health is increasing inspections and penalties for electronic cigarette offenses. Offenders face fines of 1 to 2 million VND and repeat violations will result in double fines. Authorities confiscated e-cigarette products from businesses and are enforcing Resolution No. 173/2024/QH15 to ban production and use of these products by 2025. The Ministry is amending Decree No. 117/2020/ND-CP to propose fines and confiscation of e-cigarettes for violators. Measures include destruction of products and notifying violators' workplaces or schools for appropriate action. The Ministry emphasizes the prohibition of e-cigarettes and tobacco products, urging strict enforcement and public awareness efforts.

January 23, 2025 by filtermag.org

The FDA proposed capping nicotine levels in tobacco products at a low level to reduce addiction and smoking-related harm. While the agency aims to decrease dependence, experts have concerns about potential unintended consequences, like users seeking higher-nicotine sources. Critics argue against the mandate, fearing a growth in illicit markets and limited harm reduction options. Correcting misconceptions on nicotine and risks is crucial. Implementing the plan would require accessible reduced-risk products and accurate information. The feasibility and effectiveness of such a substantial intervention remain uncertain in the US context.